These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27253772)

  • 1. Pharmacogenetics and interstitial lung disease.
    Oldham JM; Noth I; Martinez FJ
    Curr Opin Pulm Med; 2016 Sep; 22(5):456-65. PubMed ID: 27253772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
    Oldham JM; Ma SF; Martinez FJ; Anstrom KJ; Raghu G; Schwartz DA; Valenzi E; Witt L; Lee C; Vij R; Huang Y; Strek ME; Noth I;
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1475-82. PubMed ID: 26331942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
    Adegunsoye A; Vij R; Noth I
    Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of rs3750920 polymorphism in TOLLIP with clinical characteristics of fibrosing interstitial lung diseases in Japanese.
    Isshiki T; Koyama K; Homma S; Sakamoto S; Yamasaki A; Shimizu H; Miyoshi S; Nakamura Y; Kishi K
    Sci Rep; 2021 Aug; 11(1):16250. PubMed ID: 34376770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update in diffuse parenchymal lung disease, 2013.
    Rosas IO; Kaminski N
    Am J Respir Crit Care Med; 2015 Feb; 191(3):270-4. PubMed ID: 25635490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic basis of idiopathic pulmonary fibrosis.
    Kropski JA; Blackwell TS; Loyd JE
    Eur Respir J; 2015 Jun; 45(6):1717-27. PubMed ID: 25837031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin.
    Verleden GM; du Bois RM; Bouros D; Drent M; Millar A; Müller-Quernheim J; Semenzato G; Johnson S; Sourvino G; Olivier D; Pietinalho A; Xaubet A
    Eur Respir J Suppl; 2001 Sep; 32():17s-29s. PubMed ID: 11816821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances and Future Needs in Interstitial Lung Diseases.
    Jones MG; Richeldi L
    Semin Respir Crit Care Med; 2016 Jun; 37(3):477-84. PubMed ID: 27231869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Approach to Adult Fibrotic Lung Diseases.
    Adegunsoye A; Strek ME
    Chest; 2016 Dec; 150(6):1371-1386. PubMed ID: 27521738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonsynonymous polymorphism (rs117179004, T392M) of hyaluronidase 1 (HYAL1) is associated with increased risk of idiopathic pulmonary fibrosis in Southern Han Chinese.
    Liu J; Deng Y; Wang Z; Mo B; Wei J; Cheng Z; Peng Q; Wei G; Li J; Shu Y; Yang H; Fang S; Luo G; Yang S; Wang Y; Zhu J; Yang J; Wu M; Xu X; Ge R; Zhang X; Xiong W; Wang X; Li Z
    J Clin Lab Anal; 2021 Jun; 35(6):e23782. PubMed ID: 33942374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic pulmonary fibrosis: moving forward.
    Richeldi L
    BMC Med; 2015 Sep; 13():231. PubMed ID: 26399729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of Idiopathic Pulmonary Fibrosis.
    Barros A; Oldham J; Noth I
    Am J Med Sci; 2019 May; 357(5):379-383. PubMed ID: 31010464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bleomycin Model of Pulmonary Fibrosis.
    Liu T; De Los Santos FG; Phan SH
    Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited interstitial lung disease.
    Garcia CK; Raghu G
    Clin Chest Med; 2004 Sep; 25(3):421-33, v. PubMed ID: 15331184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Genetics in Interstitial Lung Disease.
    Newton CA; Molyneaux PL; Oldham JM
    Front Med (Lausanne); 2018; 5():116. PubMed ID: 29755982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapies for interstitial lung disease: past, present and future.
    Kim R; Meyer KC
    Ther Adv Respir Dis; 2008 Oct; 2(5):319-38. PubMed ID: 19124380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.